Published in Obesity and Diabetes Week, November 28th, 2005
"In the treatment of coronary stenosis, evolution after PTCA is not as good in diabetic patients compared to nondiabetic ones, whatever the treatment used. We now have data of large clinical studies which show good results of drug loaded stents in diabetic patients, especially with either a cytostatic drug (sirolimus) or a cytotoxic one (paclitaxol)," scientists in France report.
G. Drobinski and colleagues at the University of Pitie-Salpetriere explained, "In the RAVEL study, among the 44 diabetic patients, 19 had sirolimus stenting with a restenosis rate of 0% vs. a restenosis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week